Cargando…

Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era

INTRODUCTION: The widespread use of highly active antiretroviral therapy (ART) has reduced HIV-related life-threatening infectious complications. Our objective was to assess whether highly active ART was associated with improved survival in critically ill HIV-infected patients. METHODS: A retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Coquet, Isaline, Pavie, Juliette, Palmer, Pierre, Barbier, François, Legriel, Stéphane, Mayaux, Julien, Molina, Jean Michel, Schlemmer, Benoît, Azoulay, Elie
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911753/
https://www.ncbi.nlm.nih.gov/pubmed/20534139
http://dx.doi.org/10.1186/cc9056
_version_ 1782184512669614080
author Coquet, Isaline
Pavie, Juliette
Palmer, Pierre
Barbier, François
Legriel, Stéphane
Mayaux, Julien
Molina, Jean Michel
Schlemmer, Benoît
Azoulay, Elie
author_facet Coquet, Isaline
Pavie, Juliette
Palmer, Pierre
Barbier, François
Legriel, Stéphane
Mayaux, Julien
Molina, Jean Michel
Schlemmer, Benoît
Azoulay, Elie
author_sort Coquet, Isaline
collection PubMed
description INTRODUCTION: The widespread use of highly active antiretroviral therapy (ART) has reduced HIV-related life-threatening infectious complications. Our objective was to assess whether highly active ART was associated with improved survival in critically ill HIV-infected patients. METHODS: A retrospective study from 1996 to 2005 was performed in a medical intensive care unit (ICU) in a university hospital specialized in the management of immunocompromised patients. A total of 284 critically ill HIV-infected patients were included. Differences were sought across four time periods. Risk factors for death were identified by multivariable logistic regression. RESULTS: Among the 233 (82%) patients with known HIV infection before ICU admission, 64% were on highly active ART. Annual admissions increased over time, with no differences in reasons for admission: proportions of patients with newly diagnosed HIV, previous opportunistic infection, CD4 counts, viral load, or acute disease severity. ICU and 90-day mortality rates decreased steadily: 25% and 37.5% in 1996 to 1997, 17.1% and 17.1% in 1998 to 2000, 13.2% and 13.2% in 2001 to 2003, and 8.6% in 2004 to 2005. Five factors were independently associated with increased ICU mortality: delayed ICU admission (odds ratio (OR), 3.04; 95% confidence interval (CI), 1.29 to 7.17), acute renal failure (OR, 4.21; 95% CI, 1.63 to 10.92), hepatic cirrhosis (OR, 3.78; 95% CI, 1.21 to 11.84), ICU admission for coma (OR, 2.73; 95% CI, 1.16 to 6.46), and severe sepsis (OR, 3.67; 95% CI, 1.53 to 8.80). Admission to the ICU in the most recent period was independently associated with increased survival: admission from 2001 to 2003 (OR, 0.28; 95% CI, 0.08 to 0.99), and between 2004 and 2005 (OR, 0.13; 95% CI, 0.03 to 0.53). CONCLUSIONS: ICU survival increased significantly in the highly active ART era, although disease severity remained unchanged. Co-morbidities and organ dysfunctions, but not HIV-related variables, were associated with death. Earlier ICU admission from the hospital ward might improve survival.
format Text
id pubmed-2911753
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29117532010-07-29 Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era Coquet, Isaline Pavie, Juliette Palmer, Pierre Barbier, François Legriel, Stéphane Mayaux, Julien Molina, Jean Michel Schlemmer, Benoît Azoulay, Elie Crit Care Research INTRODUCTION: The widespread use of highly active antiretroviral therapy (ART) has reduced HIV-related life-threatening infectious complications. Our objective was to assess whether highly active ART was associated with improved survival in critically ill HIV-infected patients. METHODS: A retrospective study from 1996 to 2005 was performed in a medical intensive care unit (ICU) in a university hospital specialized in the management of immunocompromised patients. A total of 284 critically ill HIV-infected patients were included. Differences were sought across four time periods. Risk factors for death were identified by multivariable logistic regression. RESULTS: Among the 233 (82%) patients with known HIV infection before ICU admission, 64% were on highly active ART. Annual admissions increased over time, with no differences in reasons for admission: proportions of patients with newly diagnosed HIV, previous opportunistic infection, CD4 counts, viral load, or acute disease severity. ICU and 90-day mortality rates decreased steadily: 25% and 37.5% in 1996 to 1997, 17.1% and 17.1% in 1998 to 2000, 13.2% and 13.2% in 2001 to 2003, and 8.6% in 2004 to 2005. Five factors were independently associated with increased ICU mortality: delayed ICU admission (odds ratio (OR), 3.04; 95% confidence interval (CI), 1.29 to 7.17), acute renal failure (OR, 4.21; 95% CI, 1.63 to 10.92), hepatic cirrhosis (OR, 3.78; 95% CI, 1.21 to 11.84), ICU admission for coma (OR, 2.73; 95% CI, 1.16 to 6.46), and severe sepsis (OR, 3.67; 95% CI, 1.53 to 8.80). Admission to the ICU in the most recent period was independently associated with increased survival: admission from 2001 to 2003 (OR, 0.28; 95% CI, 0.08 to 0.99), and between 2004 and 2005 (OR, 0.13; 95% CI, 0.03 to 0.53). CONCLUSIONS: ICU survival increased significantly in the highly active ART era, although disease severity remained unchanged. Co-morbidities and organ dysfunctions, but not HIV-related variables, were associated with death. Earlier ICU admission from the hospital ward might improve survival. BioMed Central 2010 2010-06-09 /pmc/articles/PMC2911753/ /pubmed/20534139 http://dx.doi.org/10.1186/cc9056 Text en Copyright ©2010 Coquet et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Coquet, Isaline
Pavie, Juliette
Palmer, Pierre
Barbier, François
Legriel, Stéphane
Mayaux, Julien
Molina, Jean Michel
Schlemmer, Benoît
Azoulay, Elie
Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era
title Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era
title_full Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era
title_fullStr Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era
title_full_unstemmed Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era
title_short Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era
title_sort survival trends in critically ill hiv-infected patients in the highly active antiretroviral therapy era
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911753/
https://www.ncbi.nlm.nih.gov/pubmed/20534139
http://dx.doi.org/10.1186/cc9056
work_keys_str_mv AT coquetisaline survivaltrendsincriticallyillhivinfectedpatientsinthehighlyactiveantiretroviraltherapyera
AT paviejuliette survivaltrendsincriticallyillhivinfectedpatientsinthehighlyactiveantiretroviraltherapyera
AT palmerpierre survivaltrendsincriticallyillhivinfectedpatientsinthehighlyactiveantiretroviraltherapyera
AT barbierfrancois survivaltrendsincriticallyillhivinfectedpatientsinthehighlyactiveantiretroviraltherapyera
AT legrielstephane survivaltrendsincriticallyillhivinfectedpatientsinthehighlyactiveantiretroviraltherapyera
AT mayauxjulien survivaltrendsincriticallyillhivinfectedpatientsinthehighlyactiveantiretroviraltherapyera
AT molinajeanmichel survivaltrendsincriticallyillhivinfectedpatientsinthehighlyactiveantiretroviraltherapyera
AT schlemmerbenoit survivaltrendsincriticallyillhivinfectedpatientsinthehighlyactiveantiretroviraltherapyera
AT azoulayelie survivaltrendsincriticallyillhivinfectedpatientsinthehighlyactiveantiretroviraltherapyera